Published in J Am Chem Soc on February 02, 2011
Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol (2012) 3.48
Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol (2013) 2.54
Toxicity of nanomaterials. Chem Soc Rev (2011) 2.07
Focusing the research efforts. Nat Nanotechnol (2012) 1.96
Engineered nanoparticles interacting with cells: size matters. J Nanobiotechnology (2014) 1.59
Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnology (2013) 1.57
Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future. Chem Soc Rev (2012) 1.55
Impaired clearance and enhanced pulmonary inflammatory/fibrotic response to carbon nanotubes in myeloperoxidase-deficient mice. PLoS One (2012) 1.32
An integrated approach for the in vitro dosimetry of engineered nanomaterials. Part Fibre Toxicol (2014) 1.21
Silver nanoparticle protein corona composition in cell culture media. PLoS One (2013) 1.13
Validity range of centrifuges for the regulation of nanomaterials: from classification to as-tested coronas. J Nanopart Res (2012) 1.10
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems. Chem Soc Rev (2016) 1.08
Protein corona composition of superparamagnetic iron oxide nanoparticles with various physico-chemical properties and coatings. Sci Rep (2014) 1.06
Comparison of nanotube-protein corona composition in cell culture media. Small (2013) 1.06
Protein corona significantly reduces active targeting yield. Chem Commun (Camb) (2013) 1.05
Adsorption of surfactant lipids by single-walled carbon nanotubes in mouse lung upon pharyngeal aspiration. ACS Nano (2012) 1.04
Nanoparticle-cell interactions: molecular structure of the protein corona and cellular outcomes. Acc Chem Res (2014) 0.99
Microsomal glutathione transferase 1 protects against toxicity induced by silica nanoparticles but not by zinc oxide nanoparticles. ACS Nano (2012) 0.98
Altered characteristics of silica nanoparticles in bovine and human serum: the importance of nanomaterial characterization prior to its toxicological evaluation. Part Fibre Toxicol (2013) 0.98
In situ measurement of bovine serum albumin interaction with gold nanospheres. Langmuir (2012) 0.98
Safe clinical use of carbon nanotubes as innovative biomaterials. Chem Rev (2014) 0.98
eNanoMapper: harnessing ontologies to enable data integration for nanomaterial risk assessment. J Biomed Semantics (2015) 0.97
Techniques for physicochemical characterization of nanomaterials. Biotechnol Adv (2013) 0.96
Bioactive silica nanoparticles promote osteoblast differentiation through stimulation of autophagy and direct association with LC3 and p62. ACS Nano (2014) 0.96
Nanoparticle toxicity by the gastrointestinal route: evidence and knowledge gaps. Int J Biomed Nanosci Nanotechnol (2013) 0.96
Effects of surface functional groups on the formation of nanoparticle-protein corona. Appl Phys Lett (2012) 0.96
Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes. Int J Nanomedicine (2011) 0.95
Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles. PLoS One (2012) 0.95
Mapping the surface adsorption forces of nanomaterials in biological systems. ACS Nano (2011) 0.95
Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations? Toxicol Lett (2013) 0.94
Adsorption of a Protein Monolayer via Hydrophobic Interactions Prevents Nanoparticle Aggregation under Harsh Environmental Conditions. ACS Sustain Chem Eng (2013) 0.93
Interaction of colloidal nanoparticles with their local environment: the (ionic) nanoenvironment around nanoparticles is different from bulk and determines the physico-chemical properties of the nanoparticles. J R Soc Interface (2014) 0.91
Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo. ACS Nano (2015) 0.91
The effects of nanomaterials as endocrine disruptors. Int J Mol Sci (2013) 0.90
Cationic liposome/DNA complexes: from structure to interactions with cellular membranes. Eur Biophys J (2012) 0.90
The nano-plasma interface: Implications of the protein corona. Colloids Surf B Biointerfaces (2014) 0.90
Quantitative profiling of the protein coronas that form around nanoparticles. Nat Protoc (2014) 0.89
Secondary structure of corona proteins determines the cell surface receptors used by nanoparticles. J Phys Chem B (2014) 0.89
Quantum dots: an insight and perspective of their biological interaction and how this relates to their relevance for clinical use. Theranostics (2012) 0.89
Elucidation of toxicity pathways in lung epithelial cells induced by silicon dioxide nanoparticles. PLoS One (2013) 0.89
Exploiting endocytosis for nanomedicines. Cold Spring Harb Perspect Biol (2013) 0.89
Engineered nanomaterials in food: implications for food safety and consumer health. Int J Environ Res Public Health (2014) 0.89
Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles. Biomaterials (2014) 0.89
The interplay of monolayer structure and serum protein interactions on the cellular uptake of gold nanoparticles. Small (2012) 0.89
Uptake and transport of superparamagnetic iron oxide nanoparticles through human brain capillary endothelial cells. ACS Chem Neurosci (2013) 0.88
Nanoparticle-nanoparticle interactions in biological media by atomic force microscopy. Langmuir (2013) 0.88
Protein bio-corona: critical issue in immune nanotoxicology. Arch Toxicol (2016) 0.87
The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery. Nanomedicine (Lond) (2015) 0.86
High content analysis provides mechanistic insights on the pathways of toxicity induced by amine-modified polystyrene nanoparticles. PLoS One (2014) 0.86
Shrinkage of pegylated and non-pegylated liposomes in serum. Colloids Surf B Biointerfaces (2013) 0.86
Transferrin coated nanoparticles: study of the bionano interface in human plasma. PLoS One (2012) 0.86
Particle tracking in drug and gene delivery research: State-of-the-art applications and methods. Adv Drug Deliv Rev (2015) 0.86
Dynamics of nanoparticle-protein corona complex formation: analytical results from population balance equations. PLoS One (2013) 0.85
Multifunctional cationic lipid-based nanoparticles facilitate endosomal escape and reduction-triggered cytosolic siRNA release. Mol Pharm (2014) 0.85
The oxidative potential of differently charged silver and gold nanoparticles on three human lung epithelial cell types. J Nanobiotechnology (2015) 0.84
Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approaches. Int J Nanomedicine (2015) 0.84
Silver nanoparticle protein corona and toxicity: a mini-review. J Nanobiotechnology (2015) 0.84
Safety of Nanoparticles in Medicine. Curr Drug Targets (2015) 0.83
In vitro and in vivo interactions of selected nanoparticles with rodent serum proteins and their consequences in biokinetics. Beilstein J Nanotechnol (2014) 0.83
Characterization of protein adsorption onto FePt nanoparticles using dual-focus fluorescence correlation spectroscopy. Beilstein J Nanotechnol (2011) 0.83
Catalytic Properties and Biomedical Applications of Cerium Oxide Nanoparticles. Environ Sci Nano (2015) 0.83
Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity. Int J Nanomedicine (2014) 0.83
Mechanisms of Silver Nanoparticle Release, Transformation and Toxicity: A Critical Review of Current Knowledge and Recommendations for Future Studies and Applications. Materials (Basel) (2013) 0.82
Protein corona - from molecular adsorption to physiological complexity. Beilstein J Nanotechnol (2015) 0.82
Quantifying spectral changes experienced by plasmonic nanoparticles in a cellular environment to inform biomedical nanoparticle design. Nanoscale Res Lett (2014) 0.82
Alzheimer's disease: pathophysiology and applications of magnetic nanoparticles as MRI theranostic agents. ACS Chem Neurosci (2013) 0.82
Applications of surface plasmon resonance (SPR) for the characterization of nanoparticles developed for biomedical purposes. Sensors (Basel) (2012) 0.82
Nanomaterials toxicity and cell death modalities. J Drug Deliv (2012) 0.82
Quantitative measurement of intracellular transport of nanocarriers by spatio-temporal image correlation spectroscopy. Methods Appl Fluoresc (2013) 0.82
Evaluation of silica nanoparticle binding to major human blood proteins. Nanoscale Res Lett (2014) 0.81
Nanoparticle mediated drug delivery of rolipram to tyrosine kinase B positive cells in the inner ear with targeting peptides and agonistic antibodies. Front Aging Neurosci (2015) 0.81
The Protein Corona of Plant Virus Nanoparticles Influences their Dispersion Properties, Cellular Interactions, and In Vivo Fates. Small (2016) 0.81
Synthesis, characterization, and in vivo efficacy of shell cross-linked nanoparticle formulations carrying silver antimicrobials as aerosolized therapeutics. ACS Nano (2013) 0.81
Merging worlds of nanomaterials and biological environment: factors governing protein corona formation on nanoparticles and its biological consequences. Nanoscale Res Lett (2015) 0.81
Surface chemistry and serum type both determine the nanoparticle-protein corona. J Proteomics (2015) 0.81
Gold nanoparticles for cancer radiotherapy: a review. Cancer Nanotechnol (2016) 0.81
Superparamagnetic iron oxide nanoparticles alter expression of obesity and T2D-associated risk genes in human adipocytes. Sci Rep (2013) 0.80
Comparison of behaviour in different liquids and in cells of gold nanorods and spherical nanoparticles modified by linear polyethyleneimine and bovine serum albumin. Biomed Res Int (2014) 0.80
Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood. Cell Mol Bioeng (2015) 0.80
Zeolite Nanoparticles for Selective Sorption of Plasma Proteins. Sci Rep (2015) 0.80
Understanding protein-nanoparticle interaction: a new gateway to disease therapeutics. Bioconjug Chem (2014) 0.80
The Use of Synthetic Carriers in Malaria Vaccine Design. Vaccines (Basel) (2015) 0.80
Low molecular weight chitosan-coated polymeric nanoparticles for sustained and pH-sensitive delivery of paclitaxel. J Drug Target (2015) 0.79
Surface engineered antifouling optomagnetic SPIONs for bimodal targeted imaging of pancreatic cancer cells. Int J Nanomedicine (2014) 0.79
Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cells. Drug Des Devel Ther (2014) 0.79
Adsorption of cellular proteins to polyelectrolyte-functionalized gold nanorods: a mechanism for nanoparticle regulation of cell phenotype? PLoS One (2014) 0.79
Effects of surface functionalization on the adsorption of human serum albumin onto nanoparticles - a fluorescence correlation spectroscopy study. Beilstein J Nanotechnol (2014) 0.79
Delivery of cancer therapeutics to extracellular and intracellular targets: Determinants, barriers, challenges and opportunities. Adv Drug Deliv Rev (2015) 0.79
Dynamic protein coronas revealed as a modulator of silver nanoparticle sulphidation in vitro. Nat Commun (2016) 0.78
The distribution and degradation of radiolabeled superparamagnetic iron oxide nanoparticles and quantum dots in mice. Beilstein J Nanotechnol (2015) 0.78
Size dependent translocation and fetal accumulation of gold nanoparticles from maternal blood in the rat. Part Fibre Toxicol (2014) 0.78
Probing the behaviors of gold nanorods in metastatic breast cancer cells based on UV-vis-NIR absorption spectroscopy. PLoS One (2012) 0.78
Immunomodulatory properties of silver nanoparticles contribute to anticancer strategy for murine fibrosarcoma. Cell Mol Immunol (2015) 0.78
Physiological temperature has a crucial role in amyloid β in the absence and presence of hydrophobic and hydrophilic nanoparticles. ACS Chem Neurosci (2012) 0.78
Adsorption and Unfolding of a Single Protein Triggers Nanoparticle Aggregation. ACS Nano (2016) 0.78
Lipid-Mediated Targeting with Membrane-Wrapped Nanoparticles in the Presence of Corona Formation. ACS Nano (2016) 0.78
Delivery of membrane impermeable cargo into CHO cells by peptide nanoparticles targeted by a protein corona. Biomaterials (2012) 0.78
Passing through the renal clearance barrier: toward ultrasmall sizes with stable ligands for potential clinical applications. Int J Nanomedicine (2014) 0.78
Value of phagocyte function screening for immunotoxicity of nanoparticles in vivo. Int J Nanomedicine (2015) 0.78
Deformable Discoidal Polymeric Nanoconstructs for the Precise Delivery of Therapeutic and Imaging Agents. Mol Ther (2017) 0.78
Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci U S A (2007) 7.50
Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A (2008) 5.76
Biomolecular coronas provide the biological identity of nanosized materials. Nat Nanotechnol (2012) 3.48
Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed Engl (2007) 3.41
Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat Nanotechnol (2013) 3.39
Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci U S A (2007) 3.23
What the cell "sees" in bionanoscience. J Am Chem Soc (2010) 3.07
Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells. ACS Nano (2012) 2.59
Protein-nanoparticle interactions: opportunities and challenges. Chem Rev (2011) 2.34
The nanoparticle-protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interface Sci (2007) 2.22
The evolution of the protein corona around nanoparticles: a test study. ACS Nano (2011) 2.05
Detecting cryptic epitopes created by nanoparticles. Sci STKE (2006) 2.02
Protein-nanoparticle interactions: What does the cell see? Nat Nanotechnol (2009) 2.00
Role of cell cycle on the cellular uptake and dilution of nanoparticles in a cell population. Nat Nanotechnol (2011) 1.90
Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles. J Am Chem Soc (2008) 1.60
Regulator of G-protein signaling 18 integrates activating and inhibitory signaling in platelets. Blood (2012) 1.59
Complete high-density lipoproteins in nanoparticle corona. FEBS J (2009) 1.47
Nanoparticle adhesion to the cell membrane and its effect on nanoparticle uptake efficiency. J Am Chem Soc (2013) 1.44
Quantification of nanoparticle uptake by cells using an unbiased sampling method and electron microscopy. Nanomedicine (Lond) (2011) 1.43
Designing the nanoparticle-biomolecule interface for "targeting and therapeutic delivery". J Control Release (2012) 1.41
Exposure assessment: recommendations for nanotechnology-based pesticides. Int J Occup Environ Health (2011) 1.39
Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology (2010) 1.38
Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. Nano Lett (2007) 1.37
Effects of transport inhibitors on the cellular uptake of carboxylated polystyrene nanoparticles in different cell lines. PLoS One (2011) 1.36
Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona. ACS Nano (2012) 1.35
Experimental and theoretical comparison of intracellular import of polymeric nanoparticles and small molecules: toward models of uptake kinetics. Nanomedicine (2011) 1.35
Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials (2010) 1.34
In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature. Nat Methods (2005) 1.32
Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research Workshop. J Nanopart Res (2008) 1.28
Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. Nano Lett (2008) 1.25
Quantitative assessment of the comparative nanoparticle-uptake efficiency of a range of cell lines. Small (2011) 1.25
The biomolecular corona is retained during nanoparticle uptake and protects the cells from the damage induced by cationic nanoparticles until degraded in the lysosomes. Nanomedicine (2013) 1.25
Time and space resolved uptake study of silica nanoparticles by human cells. Mol Biosyst (2010) 1.25
Fate and effects of CeO2 nanoparticles in aquatic ecotoxicity tests. Environ Sci Technol (2009) 1.20
Nanotoxicology: nanoparticles reconstruct lipids. Nat Nanotechnol (2009) 1.19
Modulation of gene expression by hypoxia in human umbilical cord vein endothelial cells: A transcriptomic and proteomic study. Proteomics (2004) 1.14
Dual effect of amino modified polystyrene nanoparticles on amyloid β protein fibrillation. ACS Chem Neurosci (2010) 1.14
Nanopesticides: guiding principles for regulatory evaluation of environmental risks. J Agric Food Chem (2014) 1.12
Therapeutic nanoparticles in clinics and under clinical evaluation. Nanomedicine (Lond) (2013) 1.11
Surface-induced changes in protein adsorption and implications for cellular phenotypic responses to surface interaction. Biomaterials (2006) 1.10
Nanobiotechnology: nanoparticle coronas take shape. Nat Nanotechnol (2011) 1.09
Purification of biotinylated proteins on streptavidin resin: a protocol for quantitative elution. Proteomics (2004) 1.08
Classification framework for graphene-based materials. Angew Chem Int Ed Engl (2014) 1.06
A chemical proteomics approach for the identification of accessible antigens expressed in human kidney cancer. Mol Cell Proteomics (2006) 1.03
Novel method to prepare morphologically rich polymeric surfaces for biomedical applications via phase separation and arrest of microgel particles. J Phys Chem B (2006) 1.03
Phase equilibria and glass transition in colloidal systems with short-ranged attractive interactions: application to protein crystallization. Phys Rev E Stat Nonlin Soft Matter Phys (2002) 1.03
In vitro developmental toxicity test detects inhibition of stem cell differentiation by silica nanoparticles. Toxicol Appl Pharmacol (2009) 1.02
Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making. ACS Nano (2015) 1.01
Correlation signature of the macroscopic states of the gene regulatory network in cancer. Proc Natl Acad Sci U S A (2009) 1.01
Interaction of soft condensed materials with living cells: phenotype/transcriptome correlations for the hydrophobic effect. Proc Natl Acad Sci U S A (2003) 1.00
Protein fibrillation and nanoparticle interactions: opportunities and challenges. Nanoscale (2013) 1.00
Surface coatings shape the protein corona of SPIONs with relevance to their application in vivo. Langmuir (2012) 0.99
High-speed imaging of Rab family small GTPases reveals rare events in nanoparticle trafficking in living cells. ACS Nano (2012) 0.98
Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity. J Nanobiotechnology (2011) 0.97
A new methodology for studying nanoparticle interactions in biological systems: dispersing titania in biocompatible media using chemical stabilisers. Nanoscale (2011) 0.96
Identification and relative quantification of membrane proteins by surface biotinylation and two-dimensional peptide mapping. Proteomics (2005) 0.95
Nanoscale reference materials for environmental, health and safety measurements: needs, gaps and opportunities. Nanotoxicology (2012) 0.94
TGF-beta1-induced thrombospondin-1 expression through the p38 MAPK pathway is abolished by fluvastatin in human coronary artery smooth muscle cells. Vascul Pharmacol (2006) 0.93
Suppression of nanoparticle cytotoxicity approaching in vivo serum concentrations: limitations of in vitro testing for nanosafety. Nanoscale (2014) 0.93
Cationic nanoparticles induce caspase 3-, 7- and 9-mediated cytotoxicity in a human astrocytoma cell line. Nanotoxicology (2010) 0.93
Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay. Nanotoxicology (2010) 0.91
The Germinal centre-derived lymphomas seen through their cellular microenvironment. Br J Haematol (2008) 0.91
Elution of labile fluorescent dye from nanoparticles during biological use. PLoS One (2011) 0.90
Local drug delivery in restenosis injury: thermoresponsive co-polymers as potential drug delivery systems. Pharmacol Ther (2004) 0.89